Filtered Saliva for Rapid and Accurate Analyte Detection for POC Diagnostics.

Filtered Saliva for Rapid and Accurate Analyte Detection for POC Diagnostics.

Publication date: May 24, 2024

Saliva has shown considerable promise as a diagnostic medium for point-of-care (POC) and over-the-counter (OTC) diagnostic devices due to the non-invasive nature of its collection. However, a significant limitation of saliva-based detection is undesirable interference in a sensor’s readout caused by interfering components in saliva. In this study, we develop standardized sample treatment procedures to eliminate bubbles and interfering molecules while preserving the sample’s target molecules such as spike (S) protein and glucose. We then test the compatibility of the pretreatment system with our previously designed SARS-CoV-2 and glucose diagnostic biosensing systems for detecting S protein and glucose in subject saliva. Ultimately, the effectiveness of each filter in enhancing biomarker sensitivity is assessed. The results show that a 20 mg nylon wool (NW) filter shows an 80% change in viscosity reduction with only a 6% reduction in protein content, making it an appropriate filter for the salivary S protein diagnostic system. Meanwhile, a 30 mg cotton wool (CW) filter is identified as the optimal choice for salivary glucose detection, achieving a 90% change in viscosity reduction and a 60. 7% reduction in protein content with a minimal 4. 3% reduction in glucose content. The NW pretreatment filtration significantly improves the limit of detection (LOD) for salivary S protein detection by five times (from 0. 5 nM to 0. 1 nM) and it reduces the relative standard deviation (RSD) two times compared to unfiltered saliva. Conversely, the CW filter used for salivary glucose detection demonstrated improved linearity with an R of 0. 99 and a sensitivity of 36. 6 μA/mM.cm, over twice as high as unfiltered saliva. This unique filtration process can be extended to any POC diagnostic system and optimized for any biomarker detection, making electrochemical POC diagnostics more viable in the current market.

Open Access PDF

Concepts Keywords
Biomarker diagnostics
Cotton electrochemical biosensor
Glucose glucose
Invasive saliva
Salivary saliva filtration process
SARS-CoV-2 spike protein

Semantics

Type Source Name
drug DRUGBANK Dextrose unspecified form
disease VO effectiveness
disease IDO process
disease VO viable
disease VO USA
disease IDO blood
disease MESH COVID 19
drug DRUGBANK Coenzyme M
drug DRUGBANK Water
disease VO effective
disease MESH hepatitis
disease VO Viruses
drug DRUGBANK Gold
drug DRUGBANK Acetate ion
disease VO company
drug DRUGBANK Microcrystalline cellulose
disease VO syringe
disease IDO assay
disease VO device
disease VO mouth
drug DRUGBANK Cefotiam
drug DRUGBANK Methylergometrine
disease VO efficiency
disease VO volume
drug DRUGBANK Ademetionine
disease VO manufacturing
pathway REACTOME S Phase
drug DRUGBANK Urea
drug DRUGBANK Nitrogen
drug DRUGBANK Uric Acid
disease MESH hypertension
disease MESH Infection
disease IDO host
disease VO time
disease MESH pancreatic cancer
pathway KEGG Pancreatic cancer
disease MESH Cancers
disease MESH periodontal disease

Original Article

(Visited 2 times, 1 visits today)